Microbiome: Focus on Causation and Mechanism

Cell

Volumn 174, Issue 4, 2018, Pages 785-790

  Fischbach, Michael A ^a  

^a Stanford University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; MICROBIOME; NONHUMAN; PHENOTYPE; BACTERIAL INFECTION; HUMAN; MICROBIOLOGY; MICROFLORA;

BACTERIAL INFECTIONS; HUMANS; MICROBIOTA;

EID: 85050885001     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2018.07.038     Document Type: Review

References (59)

1. Alang, N., Kelly, C.R., Weight gain after fecal microbiota transplantation. Open Forum Infect. Dis., 2, 2015, ofv004.
2. An, D., Oh, S.F., Olszak, T., Neves, J.F., Avci, F.Y., Erturk-Hasdemir, D., Lu, X., Zeissig, S., Blumberg, R.S., Kasper, D.L., Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells. Cell 156 (2014), 123–133.
3. Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., Fukuda, S., Saito, T., Narushima, S., Hase, K., et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500 (2013), 232–236.
4. Bai, Y., Müller, D.B., Srinivas, G., Garrido-Oter, R., Potthoff, E., Rott, M., Dombrowski, N., Münch, P.C., Spaepen, S., Remus-Emsermann, M., et al. Functional overlap of the Arabidopsis leaf and root microbiota. Nature 528 (2015), 364–369.
5. Balthazart, J., Ball, G.F., Is brain estradiol a hormone or a neurotransmitter?. Trends Neurosci. 29 (2006), 241–249.
6. Bouatra, S., Aziat, F., Mandal, R., Guo, A.C., Wilson, M.R., Knox, C., Bjorndahl, T.C., Krishnamurthy, R., Saleem, F., Liu, P., et al. The human urine metabolome. PLoS ONE, 8, 2013, e73076.
7. Bravo, J.A., Forsythe, P., Chew, M.V., Escaravage, E., Savignac, H.M., Dinan, T.G., Bienenstock, J., Cryan, J.F., Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl. Acad. Sci. USA 108 (2011), 16050–16055.
8. Brown, J.M., Hazen, S.L., Metaorganismal nutrient metabolism as a basis of cardiovascular disease. Curr. Opin. Lipidol. 25 (2014), 48–53.
9. Browne, H.P., Forster, S.C., Anonye, B.O., Kumar, N., Neville, B.A., Stares, M.D., Goulding, D., Lawley, T.D., Culturing of ‘unculturable’ human microbiota reveals novel taxa and extensive sporulation. Nature 533 (2016), 543–546.
10. Buffie, C.G., Bucci, V., Stein, R.R., McKenney, P.T., Ling, L., Gobourne, A., No, D., Liu, H., Kinnebrew, M., Viale, A., et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517 (2015), 205–208.
11. Buffington, S.A., Di Prisco, G.V., Auchtung, T.A., Ajami, N.J., Petrosino, J.F., Costa-Mattioli, M., Microbial Reconstitution Reverses Maternal Diet-Induced Social and Synaptic Deficits in Offspring. Cell 165 (2016), 1762–1775.
12. Canli, T., Lesch, K.P., Long story short: the serotonin transporter in emotion regulation and social cognition. Nat. Neurosci. 10 (2007), 1103–1109.
13. Cohen, J., Pertsemlidis, A., Kotowski, I.K., Graham, R., Garcia, C.K., Hobbs, H.H., Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. Nat. Genet. 37 (2005), 161–165.
14. Cox, J.J., Reimann, F., Nicholas, A.K., Thornton, G., Roberts, E., Springell, K., Karbani, G., Jafri, H., Mannan, J., Raashid, Y., et al. An SCN9A channelopathy causes congenital inability to experience pain. Nature 444 (2006), 894–898.
15. Cullen, T.W., Schofield, W.B., Barry, N.A., Putnam, E.E., Rundell, E.A., Trent, M.S., Degnan, P.H., Booth, C.J., Yu, H., Goodman, A.L., Gut microbiota. Antimicrobial peptide resistance mediates resilience of prominent gut commensals during inflammation. Science 347 (2015), 170–175.
16. Dodd, D., Spitzer, M.H., Van Treuren, W., Merrill, B.D., Hryckowian, A.J., Higginbottom, S.K., Le, A., Cowan, T.M., Nolan, G.P., Fischbach, M.A., Sonnenburg, J.L., A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature 551 (2017), 648–652.
17. Faith, J.J., Colombel, J.-F., Gordon, J.I., Identifying strains that contribute to complex diseases through the study of microbial inheritance. Proc. Natl. Acad. Sci. USA 112 (2015), 633–640.
18. Gevers, D., Kugathasan, S., Denson, L.A., Vázquez-Baeza, Y., Van Treuren, W., Ren, B., Schwager, E., Knights, D., Song, S.J., Yassour, M., et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 15 (2014), 382–392.
19. Gilbert, J.A., Quinn, R.A., Debelius, J., Xu, Z.Z., Morton, J., Garg, N., Jansson, J.K., Dorrestein, P.C., Knight, R., Microbiome-wide association studies link dynamic microbial consortia to disease. Nature 535 (2016), 94–103.
20. Gopalakrishnan, V., Spencer, C.N., Nezi, L., Reuben, A., Andrews, M.C., Karpinets, T.V., Prieto, P.A., Vicente, D., Hoffman, K., Wei, S.C., et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359 (2018), 97–103.
21. Hsiao, E.Y., McBride, S.W., Hsien, S., Sharon, G., Hyde, E.R., McCue, T., Codelli, J.A., Chow, J., Reisman, S.E., Petrosino, J.F., et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155 (2013), 1451–1463.
22. Kosfeld, M., Heinrichs, M., Zak, P.J., Fischbacher, U., Fehr, E., Oxytocin increases trust in humans. Nature 435 (2005), 673–676.
23. Kverka, M., Zakostelska, Z., Klimesova, K., Sokol, D., Hudcovic, T., Hrncir, T., Rossmann, P., Mrazek, J., Kopecny, J., Verdu, E.F., Tlaskalova-Hogenova, H., Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition. Clin. Exp. Immunol. 163 (2011), 250–259.
24. Lagier, J.C., Khelaifia, S., Alou, M.T., Ndongo, S., Dione, N., Hugon, P., Caputo, A., Cadoret, F., Traore, S.I., Seck, E.H., et al. Culture of previously uncultured members of the human gut microbiota by culturomics. Nat. Microbiol., 1, 2016, 16203.
25. Liu, R., Paxton, W.A., Choe, S., Ceradini, D., Martin, S.R., Horuk, R., MacDonald, M.E., Stuhlmann, H., Koup, R.A., Landau, N.R., Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86 (1996), 367–377.
26. Matson, V., Fessler, J., Bao, R., Chongsuwat, T., Zha, Y., Alegre, M.L., Luke, J.J., Gajewski, T.F., The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science 359 (2018), 104–108.
27. Mazmanian, S.K., Round, J.L., Kasper, D.L., A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453 (2008), 620–625.
28. Miquel, S., Martín, R., Rossi, O., Bermúdez-Humarán, L.G., Chatel, J.M., Sokol, H., Thomas, M., Wells, J.M., Langella, P., Faecalibacterium prausnitzii and human intestinal health. Curr. Opin. Microbiol. 16 (2013), 255–261.
29. Naik, S., Bouladoux, N., Linehan, J.L., Han, S.J., Harrison, O.J., Wilhelm, C., Conlan, S., Himmelfarb, S., Byrd, A.L., Deming, C., et al. Commensal-dendritic-cell interaction specifies a unique protective skin immune signature. Nature 520 (2015), 104–108.
30. Pamer, E.G., Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens. Science 352 (2016), 535–538.
31. Panigrahi, P., Parida, S., Nanda, N.C., Satpathy, R., Pradhan, L., Chandel, D.S., Baccaglini, L., Mohapatra, A., Mohapatra, S.S., Misra, P.R., et al. A randomized synbiotic trial to prevent sepsis among infants in rural India. Nature 548 (2017), 407–412.
32. Patel, K.P., Luo, F.J., Plummer, N.S., Hostetter, T.H., Meyer, T.W., The production of p-cresol sulfate and indoxyl sulfate in vegetarians versus omnivores. Clin. J. Am. Soc. Nephrol. 7 (2012), 982–988.
33. Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490 (2012), 55–60.
34. Quera, R., Espinoza, R., Estay, C., Rivera, D., Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection. J. Crohn's Colitis 8 (2014), 252–253.
35. Ratner, M., Seres's pioneering microbiome drug fails mid-stage trial. Nat. Biotechnol. 34 (2016), 1004–1005.
36. Ridaura, V.K., Faith, J.J., Rey, F.E., Cheng, J., Duncan, A.E., Kau, A.L., Griffin, N.W., Lombard, V., Henrissat, B., Bain, J.R., et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science, 341, 2013, 1241214.
37. Romano, K.A., Martínez-Del Campo, A., Kasahara, K., Chittim, C.L., Vivas, E.I., Amador-Noguez, D., Balskus, E.P., Rey, F.E., Metabolic, Epigenetic, and Transgenerational Effects of Gut Bacterial Choline Consumption. Cell Host Microbe 22 (2017), 279–290.
38. Round, J.L., Lee, S.M., Li, J., Tran, G., Jabri, B., Chatila, T.A., Mazmanian, S.K., The Toll-LIKE receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332 (2011), 974–977.
39. Routy, B., Le Chatelier, E., Derosa, L., Duong, C.P.M., Alou, M.T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M.P., et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359 (2018), 91–97.
40. Samson, M., Libert, F., Doranz, B.J., Rucker, J., Liesnard, C., Farber, C.M., Saragosti, S., Lapoumeroulie, C., Cognaux, J., Forceille, C., et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382 (1996), 722–725.
41. Schulz, S., Green, C.K., Yuen, P.S., Garbers, D.L., Guanylyl cyclase is a heat-stable enterotoxin receptor. Cell 63 (1990), 941–948.
42. Sharon, G., Garg, N., Debelius, J., Knight, R., Dorrestein, P.C., Mazmanian, S.K., Specialized metabolites from the microbiome in health and disease. Cell Metab. 20 (2014), 719–730.
43. Shepherd, E.S., DeLoache, W.C., Pruss, K.M., Whitaker, W.R., Sonnenburg, J.L., An exclusive metabolic niche enables strain engraftment in the gut microbiota. Nature 557 (2018), 434–438.
44. Sirich, T.L., Funk, B.A., Plummer, N.S., Hostetter, T.H., Meyer, T.W., Prominent accumulation in hemodialysis patients of solutes normally cleared by tubular secretion. J. Am. Soc. Nephrol. 25 (2013), 614–622.
45. Smillie, C.S., Sauk, J., Gevers, D., Friedman, J., Sung, J., Youngster, I., Hohmann, E.L., Staley, C., Khoruts, A., Sadowsky, M.J., et al. Strain Tracking Reveals the Determinants of Bacterial Engraftment in the Human Gut Following Fecal Microbiota Transplantation. Cell Host Microbe 23 (2018), 229–240.
46. Spiegel, S., Milstien, S., Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol. 4 (2003), 397–407.
47. Surana, N.K., Kasper, D.L., Moving beyond microbiome-wide associations to causal microbe identification. Nature 552 (2017), 244–247.
48. Tang, W.H., Wang, Z., Levison, B.S., Koeth, R.A., Britt, E.B., Fu, X., Wu, Y., Hazen, S.L., Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N. Engl. J. Med. 368 (2013), 1575–1584.
49. Tang, W.H.W., Wang, Z., Kennedy, D.J., Wu, Y., Buffa, J.A., Agatisa-Boyle, B., Li, X.S., Levison, B.S., Hazen, S.L., Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ. Res. 116 (2015), 448–455.
50. Thaiss, C.A., Itav, S., Rothschild, D., Meijer, M., Levy, M., Moresi, C., Dohnalová, L., Braverman, S., Rozin, S., Malitsky, S., et al. Persistent microbiome alterations modulate the rate of post-dieting weight regain. Nature 540 (2016), 544–551.
51. Ulven, T., Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets. Front. Endocrinol. (Lausanne), 3, 2012, 111.
52. Vaishnava, S., Yamamoto, M., Severson, K.M., Ruhn, K.A., Yu, X., Koren, O., Ley, R., Wakeland, E.K., Hooper, L.V., The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science 334 (2011), 255–258.
53. van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E.G., de Vos, W.M., Visser, C.E., Kuijper, E.J., Bartelsman, J.F., Tijssen, J.G., et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368 (2013), 407–415.
54. Wahlström, A., Sayin, S.I., Marschall, H.-U., Bäckhed, F., Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism. Cell Metab. 24 (2016), 41–50.
55. Wilson, M., Microbial inhabitants of humans: their ecology and role in health and disease. 2005, Cambridge University Press, New York.
56. Winter, S.E., Winter, M.G., Xavier, M.N., Thiennimitr, P., Poon, V., Keestra, A.M., Laughlin, R.C., Gomez, G., Wu, J., Lawhon, S.D., et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science 339 (2013), 708–711.
57. Xu, M., Pokrovskii, M., Ding, Y., Yi, R., Au, C., Harrison, O.J., Galan, C., Belkaid, Y., Bonneau, R., Littman, D.R., c-MAF-dependent regulatory T cells mediate immunological tolerance to a gut pathobiont. Nature 554 (2018), 373–377.
58. Yang, Y., Torchinsky, M.B., Gobert, M., Xiong, H., Xu, M., Linehan, J.L., Alonzo, F., Ng, C., Chen, A., Lin, X., et al. Focused specificity of intestinal TH17 cells towards commensal bacterial antigens. Nature 510 (2014), 152–156.
59. Zhu, W., Gregory, J.C., Org, E., Buffa, J.A., Gupta, N., Wang, Z., Li, L., Fu, X., Wu, Y., Mehrabian, M., et al. Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk. Cell 165 (2016), 111–124.